These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 29181691)

  • 21. Humanized Mice Engrafted With Human HSC Only or HSC and Thymus Support Comparable HIV-1 Replication, Immunopathology, and Responses to ART and Immune Therapy.
    Cheng L; Ma J; Li G; Su L
    Front Immunol; 2018; 9():817. PubMed ID: 29725337
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Escape from humoral immunity is associated with treatment failure in HIV-1-infected patients receiving long-term antiretroviral therapy.
    Ouyang Y; Yin Q; Li W; Li Z; Kong D; Wu Y; Hong K; Xing H; Shao Y; Jiang S; Ying T; Ma L
    Sci Rep; 2017 Jul; 7(1):6222. PubMed ID: 28740221
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Antibody-dependent effector functions against HIV decline in subjects receiving antiretroviral therapy.
    Madhavi V; Ana-Sosa-Batiz FE; Jegaskanda S; Center RJ; Winnall WR; Parsons MS; Ananworanich J; Cooper DA; Kelleher AD; Hsu D; Pett S; Stratov I; Kramski M; Kent SJ
    J Infect Dis; 2015 Feb; 211(4):529-38. PubMed ID: 25170105
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immune activation and increased IL-21R expression are associated with the loss of memory B cells during HIV-1 infection.
    Ruffin N; Lantto R; Pensieroso S; Sammicheli S; Hejdeman B; Rethi B; Chiodi F
    J Intern Med; 2012 Nov; 272(5):492-503. PubMed ID: 22530560
    [TBL] [Abstract][Full Text] [Related]  

  • 25. HIV-1-infected children on HAART: immunologic features of three different levels of viral suppression.
    Zaccarelli-Filho CA; Ono E; Machado DM; Brunialti M; Succi RC; Salomão R; Kallás EG; de Moraes-Pinto MI
    Cytometry B Clin Cytom; 2007 Jan; 72(1):14-21. PubMed ID: 17041945
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The role of latency reversal agents in the cure of HIV: A review of current data.
    Bashiri K; Rezaei N; Nasi M; Cossarizza A
    Immunol Lett; 2018 Apr; 196():135-139. PubMed ID: 29427743
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Impact of monotherapy on HIV-1 reservoir, immune activation, and co-infection with Epstein-Barr virus.
    Petrara MR; Cattelan AM; Sasset L; Freguja R; Carmona F; Sanavia S; Zanchetta M; Del Bianco P; De Rossi A
    PLoS One; 2017; 12(9):e0185128. PubMed ID: 28926641
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Impaired CD4+ T-cell restoration in the small versus large intestine of HIV-1-positive South Africans receiving combination antiretroviral therapy.
    Cassol E; Malfeld S; Mahasha P; Bond R; Slavik T; Seebregts C; Poli G; Cassol S; van der Merwe SW; Rossouw T
    J Infect Dis; 2013 Oct; 208(7):1113-22. PubMed ID: 23749968
    [TBL] [Abstract][Full Text] [Related]  

  • 29. B cell immunopathology during HIV-1 infection: lessons to learn for HIV-1 vaccine design.
    Cagigi A; Nilsson A; De Milito A; Chiodi F
    Vaccine; 2008 Jun; 26(24):3016-25. PubMed ID: 18164520
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Reversible Reprogramming of Circulating Memory T Follicular Helper Cell Function during Chronic HIV Infection.
    Cubas R; van Grevenynghe J; Wills S; Kardava L; Santich BH; Buckner CM; Muir R; Tardif V; Nichols C; Procopio F; He Z; Metcalf T; Ghneim K; Locci M; Ancuta P; Routy JP; Trautmann L; Li Y; McDermott AB; Koup RA; Petrovas C; Migueles SA; Connors M; Tomaras GD; Moir S; Crotty S; Haddad EK
    J Immunol; 2015 Dec; 195(12):5625-36. PubMed ID: 26546609
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapeutic immunisation plus cytokine and hormone therapy improves CD4 T-cell counts, restores anti-HIV-1 responses and reduces immune activation in treated chronic HIV-1 infection.
    Herasimtschuk A; Downey J; Nelson M; Moyle G; Mandalia S; Sikut R; Adojaan M; Stanescu I; Gotch F; Imami N
    Vaccine; 2014 Dec; 32(51):7005-7013. PubMed ID: 25454870
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Low frequency of plasma nerve-growth factor detection is associated with death of memory B lymphocytes in HIV-1 infection.
    Titanji K; Nilsson A; Mörch C; Samuelsson A; Sönnerborg A; Grutzmeier S; Zazzi M; De Milito A
    Clin Exp Immunol; 2003 May; 132(2):297-303. PubMed ID: 12699420
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HIV-dependent depletion of influenza-specific memory B cells impacts B cell responsiveness to seasonal influenza immunisation.
    Wheatley AK; Kristensen AB; Lay WN; Kent SJ
    Sci Rep; 2016 May; 6():26478. PubMed ID: 27220898
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Changes in blood B cell phenotypes and Epstein-Barr virus load in chronically human immunodeficiency virus–infected patients before and after antiretroviral therapy.
    Richard Y; Amiel C; Jeantils V; Mestivier D; Portier A; Dhello G; Feuillard J; Creidy R; Nicolas JC; Raphael M
    J Infect Dis; 2010 Nov; 202(9):1424-34. PubMed ID: 20874514
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Zoledronic acid and interleukin-2 treatment improves immunocompetence in HIV-infected persons by activating Vgamma9Vdelta2 T cells.
    Poccia F; Gioia C; Martini F; Sacchi A; Piacentini P; Tempestilli M; Agrati C; Amendola A; Abdeddaim A; Vlassi C; Malkovsky M; D'Offizi G
    AIDS; 2009 Mar; 23(5):555-65. PubMed ID: 19238075
    [TBL] [Abstract][Full Text] [Related]  

  • 36. HIV Maintains an Evolving and Dispersed Population in Multiple Tissues during Suppressive Combined Antiretroviral Therapy in Individuals with Cancer.
    Rose R; Lamers SL; Nolan DJ; Maidji E; Faria NR; Pybus OG; Dollar JJ; Maruniak SA; McAvoy AC; Salemi M; Stoddart CA; Singer EJ; McGrath MS
    J Virol; 2016 Oct; 90(20):8984-93. PubMed ID: 27466425
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Memory B cell function in HIV-infected children-decreased memory B cells despite ART.
    Ghosh S; Feyen O; Jebran AF; Huck K; Jetzek-Zader M; Bas M; Niehues T
    Pediatr Res; 2009 Aug; 66(2):185-90. PubMed ID: 19390488
    [TBL] [Abstract][Full Text] [Related]  

  • 38. HIV-Tat immunization induces cross-clade neutralizing antibodies and CD4(+) T cell increases in antiretroviral-treated South African volunteers: a randomized phase II clinical trial.
    Ensoli B; Nchabeleng M; Ensoli F; Tripiciano A; Bellino S; Picconi O; Sgadari C; Longo O; Tavoschi L; Joffe D; Cafaro A; Francavilla V; Moretti S; Pavone Cossut MR; Collacchi B; Arancio A; Paniccia G; Casabianca A; Magnani M; Buttò S; Levendal E; Ndimande JV; Asia B; Pillay Y; Garaci E; Monini P;
    Retrovirology; 2016 Jun; 13(1):34. PubMed ID: 27277839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Maintenance of HIV-Specific Memory B-Cell Responses in Elite Controllers Despite Low Viral Burdens.
    Buckner CM; Kardava L; Zhang X; Gittens K; Justement JS; Kovacs C; McDermott AB; Li Y; Sajadi MM; Chun TW; Fauci AS; Moir S
    J Infect Dis; 2016 Aug; 214(3):390-8. PubMed ID: 27122593
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Memory B cell dysregulation in HIV-1-infected individuals.
    Carrillo J; Negredo E; Puig J; Molinos-Albert LM; Rodríguez de la Concepción ML; Curriu M; Massanella M; Navarro J; Crespo M; Viñets E; Millá F; Clotet B; Blanco J
    AIDS; 2018 Jan; 32(2):149-160. PubMed ID: 29112067
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.